Strumento inattivo

Azioni Islet Sciences Inc OTC Bulletin Board

Azioni

Prezzo di chiusura OTC Bulletin Board Altri mercati azionari
- ^USD	-

Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH	04/05/15
Islet Sciences, Inc. Presented at 50th International Liver Conference	23/04/15
Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum	24/03/15
Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)	09/03/15
Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD	05/03/15

Settore

	Variaz. 1 gen.	Capi.
IQVIA HOLDINGS INC.	+1,77%	42,86 Mrd
LONZA GROUP AG	+45,32%	41,36 Mrd
MODERNA, INC.	+12,24%	42,74 Mrd
CELLTRION, INC.	-8,83%	27,68 Mrd
ICON PUBLIC LIMITED COMPANY	+7,44%	25,15 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-23,01%	18,63 Mrd
MEDPACE HOLDINGS, INC.	+30,56%	12,37 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1,82%	11,92 Mrd
UNITED THERAPEUTICS CORPORATION	+8,35%	11,21 Mrd